Search

everythinglearnresearchcommunity

for

Search:↓

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Stem cells are present in goat hair follicles but decrease over time.

A new one-step test can quickly identify skin cancer during surgery.

Injecting a cell suspension from hair follicles increased hair density in a balding patient.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

CD133+ cells are crucial for hair growth.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

Researchers made a cell line that grows quickly and can help with hair growth research.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

People with acne have more CD4+ immune cells in their skin than healthy people.

Six months after COVID-19, most patients still had autoantibodies.

Anti-CD19 therapy may help treat SLE and NMOSD.

Targeting CD169+ skin macrophages may help treat psoriasis.

B cells can both help and hinder the body's defense against melanoma.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.